Key Highlights
- ARK Invest acquired 85,485 shares of Palantir valued at approximately $11.15M distributed across five ETFs
- The firm divested 44,446 AMD shares totaling roughly $10.52M, scaling back semiconductor holdings
- Palantir shares declined approximately 2% Friday following Thursday’s 7% retreat
- Michael Burry flagged Palantir as “bubble”-valued, pointing to Anthropic’s competitive momentum
- Wedbush analyst Daniel Ives countered Burry’s position, reaffirming Buy rating with $230 target
Cathie Wood’s investment management firm, ARK Invest, executed significant portfolio adjustments during April 10-11, 2026. The fund manager purchased Palantir Technologies stock while simultaneously reducing its Advanced Micro Devices holdings, based on the company’s published daily transaction reports.
ARK accumulated 85,485 Palantir shares representing approximately $11.15 million in value. The acquisition was distributed among five exchange-traded funds: ARKK acquired 46,455 shares, ARKQ added 15,127, ARKW purchased 11,865, ARKF bought 5,973, and ARKX obtained 6,065.
Palantir Technologies Inc., PLTR
Concurrently, ARK divested 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in total value. These sales were similarly allocated across the identical five fund portfolios.
These transactions indicate ARK’s strategic pivot from semiconductor hardware investments toward artificial intelligence software platforms.
Market Turbulence Hits Palantir
Palantir’s stock experienced significant headwinds during the week preceding ARK’s purchase. The shares retreated approximately 2% Friday after suffering a 7% decline the previous session.
A portion of this downturn stemmed from commentary by Michael Burry, the prominent investor famous for “The Big Short” trade. Burry published remarks on X suggesting Palantir’s market valuation has entered “bubble” levels.
Burry contended that Anthropic, the emerging AI company, is capturing market share from Palantir through its innovative “Mythos” model and accelerated expansion. Cathie Wood apparently viewed the price weakness as an attractive entry point.
ARK additionally liquidated 75,389 shares of Strata Critical Medical worth $305,325, extending a pattern of reducing exposure to that equity during recent sessions.
Wall Street Opinions Remain Split
Burry’s perspective doesn’t enjoy universal support. Wedbush analyst Daniel Ives characterized Burry’s viewpoint as a “fictional narrative.”
Ives maintained his Buy recommendation on Palantir while keeping his price objective at $230. He highlighted Palantir’s impressive 137% expansion in U.S. Commercial revenue as proof that the company’s competitive advantages remain intact.
Benchmark analyst Yi Fu Lee takes a more reserved stance. Lee suggests that Palantir’s elevated valuation metrics require continued strong operational performance to support current stock prices.
The Street consensus on Palantir currently stands at Moderate Buy. This rating reflects 14 Buy recommendations, 5 Hold ratings, and 2 Sell calls.
The mean price objective following the recent market turbulence reaches $194.61, implying roughly 52% appreciation potential from Friday’s closing price.
Advanced Micro Devices shares advanced 3.55% during the same trading session when ARK executed its sale.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
